Search Results

There are 20141 results for: content related to: Ongoing Self-Engagement in Quit Attempts and Cessation Outcomes Among Rural Smokers Who Were Unable to Quit After 2 Years of Repeated Interventions

  1. You have free access to this content
    Nicotine receptor partial agonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Kate Cahill, Nicola Lindson-Hawley, Kyla H Thomas, Thomas R Fanshawe and Tim Lancaster

    Published Online : 9 MAY 2016, DOI: 10.1002/14651858.CD006103.pub7

  2. You have free access to this content
    Pharmacological interventions for smoking cessation: an overview and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Kate Cahill, Sarah Stevens, Rafael Perera and Tim Lancaster

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD009329.pub2

  3. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial

    Addiction

    Volume 109, Issue 9, September 2014, Pages: 1554–1563, Shadi Nahvi, Yuming Ning, Kate S. Segal, Kimber P. Richter and Julia H. Arnsten

    Version of Record online : 27 JUN 2014, DOI: 10.1111/add.12631

  4. Use of stop-smoking medications in the United States before and after the introduction of varenicline

    Addiction

    Volume 110, Issue 2, February 2015, Pages: 346–355, Karin A. Kasza, K. Michael Cummings, Matthew J. Carpenter, Monica E. Cornelius, Andrew J. Hyland and Geoffrey T. Fong

    Version of Record online : 20 NOV 2014, DOI: 10.1111/add.12778

  5. A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities

    Journal of Evaluation in Clinical Practice

    Volume 17, Issue 2, April 2011, Pages: 288–297, Evelina A. Zimovetz, Koo Wilson, Miny Samuel and Stephen M. Beard

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1365-2753.2010.01439.x

  6. Effectiveness of stop-smoking medications: findings from the International Tobacco Control (ITC) Four Country Survey

    Addiction

    Volume 108, Issue 1, January 2013, Pages: 193–202, Karin A. Kasza, Andrew J. Hyland, Ron Borland, Ann D. McNeill, Maansi Bansal-Travers, Brian V. Fix, David Hammond, Geoffrey T. Fong and K. Michael Cummings

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1360-0443.2012.04009.x

  7. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy

    Addiction

    Volume 108, Issue 8, August 2013, Pages: 1497–1502, Eva Kralikova, Alexandra Kmetova, Lenka Stepankova, Kamila Zvolska, Rachel Davis and Robert West

    Version of Record online : 13 MAY 2013, DOI: 10.1111/add.12219

  8. Prescribing of smoking cessation medication in England since the introduction of varenicline

    Addiction

    Volume 106, Issue 7, July 2011, Pages: 1319–1324, Tessa E. Langley, Yue Huang, Ann McNeill, Tim Coleman, Lisa Szatkowski and Sarah Lewis

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1360-0443.2011.03426.x

  9. You have full text access to this OnlineOpen article
    Retreatment With Varenicline for Smoking Cessation in Smokers Who Have Previously Taken Varenicline: A Randomized, Placebo-Controlled Trial

    Clinical Pharmacology & Therapeutics

    Volume 96, Issue 3, September 2014, Pages: 390–396, D Gonzales, P Hajek, L Pliamm, K Nackaerts, L-J Tseng, T D McRae and J Treadow

    Version of Record online : 9 JUN 2014, DOI: 10.1038/clpt.2014.124

  10. Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 1, July 2010, Pages: 109–114, K A Perkins, C Lerman, C A Fonte, M Mercincavage, M L Stitzer, K N R Chengappa and A Jain

    Version of Record online : 19 MAY 2010, DOI: 10.1038/clpt.2010.65

  11. Use of the Patient Health Questionnaire-2 to Predict Suicidal Ideations in Patients Taking Varenicline

    The American Journal on Addictions

    Volume 21, Issue 4, July/August 2012, Pages: 356–362, Christopher M. Cowan, Jennifer S. Wink and Kent J. DeZee

    Version of Record online : 16 MAY 2012, DOI: 10.1111/j.1521-0391.2012.00243.x

  12. ‘Real-world’ effectiveness of smoking cessation treatments: a population study

    Addiction

    Volume 109, Issue 3, March 2014, Pages: 491–499, Daniel Kotz, Jamie Brown and Robert West

    Version of Record online : 20 DEC 2013, DOI: 10.1111/add.12429

  13. Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation

    International Journal of Clinical Practice

    Volume 66, Issue 2, February 2012, Pages: 171–182, M. Mahmoudi, C. I. Coleman and D. M. Sobieraj

    Version of Record online : 19 JAN 2012, DOI: 10.1111/j.1742-1241.2011.02877.x

  14. Abstinence and relapse among smokers who use varenicline in a quit attempt—a pooled analysis of randomized controlled trials

    Addiction

    Volume 110, Issue 7, July 2015, Pages: 1182–1193, Shade A. Agboola, Tim Coleman, Ann McNeill and Jo Leonardi-Bee

    Version of Record online : 12 JUN 2015, DOI: 10.1111/add.12941

  15. You have free access to this content
    Pre-clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 334–345, H Rollema, A Shrikhande, KM Ward, FD Tingley III, JW Coe, BT O'Neill, E Tseng, EQ Wang, RJ Mather, RS Hurst, KE Williams, M de Vries, T Cremers, S Bertrand and D Bertrand

    Version of Record online : 22 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00682.x

  16. Efficacy of the nicotine vaccine 3′-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial

    Addiction

    Volume 109, Issue 8, August 2014, Pages: 1252–1259, Philippe H. J. Hoogsteder, Daniel Kotz, Paul I. van Spiegel, Wolfgang Viechtbauer and Onno C. P. van Schayck

    Version of Record online : 3 JUN 2014, DOI: 10.1111/add.12573

  17. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats

    Addiction Biology

    Volume 20, Issue 2, March 2015, Pages: 248–258, Wouter Goutier, Margreet B. Kloeze and Andrew C. McCreary

    Version of Record online : 20 NOV 2013, DOI: 10.1111/adb.12108

  18. Australian smokers increasingly use help to quit, but number of attempts remains stable: findings from the International Tobacco Control Study 2002–09

    Australian and New Zealand Journal of Public Health

    Volume 35, Issue 4, August 2011, Pages: 368–376, Jae Cooper, Ron Borland and Hua-Hie Yong

    Version of Record online : 2 AUG 2011, DOI: 10.1111/j.1753-6405.2011.00733.x

  19. You have free access to this content
    Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice

    International Journal of Clinical Practice

    Volume 67, Issue 5, May 2013, Pages: 469–476, C. Wang, B. Cho, D. Xiao, D. Wajsbrot and P. W. Park

    Version of Record online : 11 APR 2013, DOI: 10.1111/ijcp.12121

  20. Effects of Varenicline on Ethanol-Induced Conditioned Place Preference, Locomotor Stimulation, and Sensitization

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3033–3042, Noah R. Gubner, Carrie S. McKinnon and Tamara J. Phillips

    Version of Record online : 7 JAN 2015, DOI: 10.1111/acer.12588